Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
dc.contributor.author | Jaeger, Marianna de Barros | pt_BR |
dc.contributor.author | Miná, Camila Schorr | pt_BR |
dc.contributor.author | Alves, Sofia Giusti | pt_BR |
dc.contributor.author | Schuh, Gabriela Jungblut | pt_BR |
dc.contributor.author | Wender, Maria Celeste Osório | pt_BR |
dc.contributor.author | Manfro, Gisele Gus | pt_BR |
dc.date.accessioned | 2022-04-13T04:51:38Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.issn | 1516-4446 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/237158 | pt_BR |
dc.description.abstract | Objective: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect symptoms. Methods: A cross-sectional study was conducted with 89 perimenopausal women aged 45-55 years. Broad psychiatric and clinical evaluations were carried out. The primary outcome was the vasomotor symptom problem rating and the main study factor was anxiety sensitivity. Linear regression analyses were conducted to examine the associations between the study factors and the primary outcome, and a multiple regression model was created to assess which variables were independently associated with vasomotor symptom problem rating. Results: The prevalence of anxiety, depression, and vasomotor symptoms were 58, 62, and 73%, respectively. Negative affect symptoms were positively associated with vasomotor symptom problem rating. The association of anxiety sensitivity and vasomotor symptom problem rating remained significant after controlling for perimenopausal stage, thyrotropin, follicle-stimulating hormone levels, and psychotropic medication use (b = 0.314, p = 0.002). Conclusion: A better understanding of the experience of vasomotor symptoms is needed, especially the role of negative affect symptoms and anxiety sensitivity. New strategies focusing on related thoughts and behaviors could improve the quality of life of perimenopausal women. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Revista brasileira de psiquiatria (1999). São Paulo. Vol. 43, n. 3 (May/June 2021), p. 277-284. | pt_BR |
dc.rights | Open Access | en |
dc.subject | Anxiety | en |
dc.subject | Ansiedade | pt_BR |
dc.subject | Depression | en |
dc.subject | Depressão | pt_BR |
dc.subject | Perimenopause | en |
dc.subject | Perimenopausa | pt_BR |
dc.title | Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001139273 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Files in this item
This item is licensed under a Creative Commons License
-
Journal Articles (40229)Health Sciences (10752)